# Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin

> **NCT01866462** · EARLY_PHASE1 · COMPLETED · sponsor: **NuMe Health** · enrollment: 10 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **OTHER:** NM504

## Key facts

- **NCT ID:** NCT01866462
- **Lead sponsor:** NuMe Health
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2014-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01866462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01866462, "Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01866462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*